Virtual 14TH ETHICS Int'l Pharma & Med Device Ethics and Compliance Congress Features Role of Analytics and Behavioral Science in Successful Compliance Programs
  • Virtual Online Video Event Live and 6 Months Access to Video Archive
  • Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
  • Media Partners: Policy & Medicine Compliance Update
  • June 14-17, 2021
Phone: 800-503-8171
Click Here for agenda.

Click Here to register by May 14 for early bird discount.

Early bird registration discounts now available with special ETHICS/EFPIA/FSA/IFPMA/MedTech Europe/PCF rates. Rates are up to €1,000 less than major competing events.
- Click Here -


Amanda Bunten, DPsych
Chartered Health Psychologist; Director of Behavioral Ethics, GlaxoSmithKline;Former Principal Behavioural Insights Advisor,Public Health England, London, UK

Caitlin Handron, PhD
Senior Lab Consultant and Behavioral Scientist, R&G Insights Lab, Ropes & Gray LLP, Silicon Valley, CA

Tara Palesh, MS
Senior Director, Compliance Analytics Lead, Pfizer, New York, NY, USA

Sapan Singh, MBA
Senior Director Compliance, Stryker Corporation, Mahwah, NJ, USA

Zachary N. Coseglia, JD
Managing Principal and Head of Innovation, R&G Insights Lab, Ropes & Gray, LLP, Boston, MA, USA (Co-Discussion Coordinator)

Amanda N. Raad, JD
Partner and Co-Chair of Global Anti-Corruption and International Risk Practice and R&G Insights Lab, Ropes & Gray, LLP, London, UK (Co-Discussion Coordinator)

PARIS, FRANCE -- HEALTHCARE UPDATE NEWS SERVICE™ -- MAY 6, 2021: The Virtual Fourteenth International Pharmaceutical and Medical Device Ethics and Compliance Congress,, has been rescheduled to June 14 - 17, 2021, will take place in the form of online video broadcast which will be offered live and archived for 6 months following the live broadcast.


Hani Abouhalka, MBA
Company Group Chairman, Medical Devices EMEA, Johnson & Johnson, New Brunswick, NJ, USA

Gemma Aiolfi
Head of Compliance, Corporate Governance and Collective Action, Basel, Switzerland

Pedro Carrascal, MBA
President, European Multiple Sclerosis Platform (EMSP), Chief Executive Officer, EME (Multiple Sclerosis Spain), Biscay MS Society and MS Basque Foundation, Board, Multiple Sclerosis International Federation (MSIF), Bilbao, Spain

Roxana Family, Thèse de Doctorat Droit
Vice-President, Chair in Law & Business Ethics and Program Director, Cergy Pontoise University, Cergy-Pontoise, France

Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission; Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan; Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC, USA

David Fuhr, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA

Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna; Former European Compliance Director, Otsuka; Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb; Yardley, PA, USA

Anna-Elisabeth Krause-Ablass, JD
European Delegated Prosecutor, European Public Prosecutor's Office; Former Specialized Public Prosecutor for White Collar Crime Frankfurt, Frankfurt, Germany

Judy Krieg, MS, JD
Head of Fraud, Bribery and Corruption, Division B, UK Serious Fraud Office;
Former Chief Compliance Officer, Rolls-Royce plc; London, UK

Sally Molloy, JD
Chief, Strategy, Policy & Training Unit, Fraud Section; Former Assistant U.S. Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice; Washington, DC, USA

Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo; Former Compliance Director Western Europe & Canada, AbbVie; Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb; Paris, France

N. Craig Smith
Chaired Professor of Ethics and Social Responsibility, Academic Director of ESRI (the INSEAD Ethics and Social Responsibility Initiative), and Programme Director for the Healthcare Compliance, Implementation Leadership Programme, INSEAD, Fontainebleau, France


Adam Dubow, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ, USA

Mwana Lugogo, JD, MPP
Chief Ethics and Compliance Officer, Takeda Pharmaceuticals International GmBh, Zurich, Switzerland

Lori Russell, JD
Chief Compliance Officer, bioMerieux, Lyon, France

Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee F. Hoffmann-La Roche Ltd, Basel, Switzerland

Trudy Tan
Global Head Ethics, Risk & Compliance, Pharma, Novartis; Former Vice President Compliance, International, AstraZeneca; Basel, Switzerland

Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, Poland


Matt Abrahamson, MBA
Senior Compliance Analyst, DH Diagnostics LLC, a Danaher company, Buffalo Grove, IL, USA

Michaela Ahlberg, LLM, CCEP, CCEP-I
Senior Advisor, Getinge; Former Ethics & Compliance and Anti Bribery Corruption specialist, TheGreyZone, Göteborgsområdet, Sweden

Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis; Mexico City, Mexico

Ghadeer Al Yacoub, MSc
Regional Head Healthcare Compliance Europe, Middle East and Africa Medical Devices, Johnson & Johnson, Dubai, UAE

Bas Amesz, MSc
Partner, Vintura, Baarn, Utrecht, Netherlands

Michael Bartke, PhD
Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Strategic Committee, ETHICS, Munich, Germany

Ann Beasley, JD
Chief Compliance Officer, Zai Lab; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Global Compliance Office, Novartis Pharma AG; Boston, MA, USA

Duygu Beyazo, LLB
Senior Associate, NSN Law Firm; Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences; Istanbul, Turkey

Stefano Biondi, LLB, PhD
Compliance Manager and Group Data Protection Officer, Menarini Group, Florence, Italy

Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC; Contributing Editor, FCPA Blog; Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ; New York, NY, USA

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA

Julie Bonhomme
Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Amanda Bunten, PhD
Chartered Health Psychologist; Director of Behavioral Ethics, GlaxoSmithKline;Former Principal Behavioural Insights Advisor,Public Health England, London, UK

Keith Burn
Global Investigations Director, Ipsen; Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS; Former Detective Constable, London Metropolitan Police; Slough, UK

Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme; Former Senior Manager NA Compliance, Sanofi; Jamaica Plain, MA, USA

Kishwar Chishty, ACA
Partner Risk Advisory Life Sciences, Deloitte Switzerland, Basel, Switzerland

Ana Christian, JD
Senior Director, Assistant General Counsel, Avanir Pharmaceuticals; Former Corporate Counsel, NantHealth,Los Angeles, CA, USA

Michael R. Clarke, JD, CCEP
Vice President, Global Chief Compliance Officer, ConvaTec; Former Vice President, Corporate Compliance, Indivior; Former Vice President, Ethics & Compliance, Americas, Actavis; Bridgewater, NJ, USA

Zachary N. Coseglia, JD
Managing Principal and Head of Innovation, R&G Insights Lab, Ropes & Gray, LLP, Boston, MA, USA

Rika De Ville
Vice President Global Compliance & Privacy, Data Protection Officer, Perrigo Company plc Nazareth, Belgium

Stefanie Deronne, JD
Legal Counsel, Argenx; Former Senior Corporate Legal Counsel R&D - DPO, Ablynx; Ghent, Belgium

Anisa Dhalla
Global Chief Compliance Officer, UCB, Inc., Atlanta, GA, USA

Holger Diener
Healthcare Compliance Officer, Janssen-Cilag GmbH, Johnson & Johnson; Former Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry (“FSA”), Berlin, Germany

Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany

Kalwant Dhindsa, CIPP/E, CCEP
Compliance Director, Convatec; Former Senior Corporate Compliance Counsel, Bayer; Reading, UK

Laetitia Ducroquet
Vice-President, Global Business Ethics, Ipsen, Boulogne Billancourt, France

Julien Durand, MBA, PhD
Vice President, Head of Transformation, Global Ethics & Compliance, Takeda Chair, Future Health Technologies & Bioethics Working Groups, IFPMA; Former Executive Director Compliance & Ethics, Amgen; Former Chief Privacy Officer and Global Technology Compliance Head, AstraZeneca; Zürich, Switzerland

Sue Egan
Director and Principal Consultant, Sue Egan Associates; Former Vice President Compliance, AstraZeneca; Great Missenden, Buckinghamshire, UK

Signe Elbæk, JD, LLM
Former Group Chief Compliance Officer, Coloplast; Former Vice Chair, Ethics and Compliance Committee and Member of the Code Committee, MedTech Europe; Former Compliance Manager, Attorney, Dako Denmark A/S; Copenhagen, Denmark

Jacob Elberg, JD
Associate Professor, Seton Hall University School of Law; Former Chief, Health Care & Government Fraud Unit, and Assistant US Attorney US Attorney's Office, District of New Jersey; Newark, NJ, USA

Robert Ennis, JD, LLM
Vice President and Lead Compliance Counsel, Pfizer, New York, NY

Martin Eschbach, JD
Head Ethics, Risk and Compliance and Legal Patient Engagement, Novartis International AG, Baden-Württemberg, Germany

Steffen Esche
Director, Consulting, Risk & Regulatory, PwC, Frankfurt, Germany

J. Mark Farrar, MSJ, CPA, CFE, CFF, CIPP/US
Partner, Life Sciences Governance, Risk Management and Compliance, Guidehouse; Former Interim Chief Global Compliance Officer, Beckman Coulter, Atlanta, GA

Alex Fell
Head Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GSK; London, UK

George Fife
Partner, Forensic & Integrity Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Sylvie Gallage-Alwis, DEA, LLM
Partner, Signature Litigation Avocat à la Cour Solicitor in England & Wales Committees Vice Chair, International Association of Defense Counsel, Paris, France

Abhiroop Gandhi
Trust and Compliance Officer, Verily Life Sciences (an Alphabet company), Former Vice President, Corporate Compliance, Mallinckrodt, San Francisco, CA, USA

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division; Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC

Tom Gregory
Partner, Fraud Investigation & Dispute Services, Ernst & Young, LLP, Atlanta, GA

Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany

Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA

Joseph W. Henein, PharmD
President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE

Bella Rafael Hovhannisyan
Acting Chief Compliance Officer, Business Integrity Lead, Intercontinental, CSL Bering; Former Compliance & Ethics Lead, Spain & Portugal, Russia & Turkey, Bristol-Myers Squibb; Berne, Switzerland

Mirgen Jaku, MA
Lead of Market Readiness, Digital Surgery, EMEA, Johnson & Johnson, Hamburg, Germany

Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland

Els Janssens, LLM
Counsel, Baker & McKenzie; Former Legal Adviser, European Medicines Agency; Former Senior Legal Counsel, Johnson & Johnson; Brussels, Belgium

Larisa K. Jasnic, LLB, LLM
Head of Ethics & Compliance, International, Alnylam Pharmaceuticals; Former Regional Compliance Officer, Region Europe, Novartis; Zug, Switzerland

Chelsea M. Keeton, JD
Director and Senior Counsel, Global Compliance Investigations, Zimmer Biomet; Former Group Ethics & Compliance Counsel, VEON, Amsterdam, Netherlands

Iordanis Kerenidis, PhD
Director, Paris Centre for Quantum Computing (PCQC) CNRS Senior Researcher (DR2), Algorithms and Complexity Group IRIF, University Paris Diderot, Paris, France

Elisabeth Kohoutek
Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany

Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA

Adem Koyuncu, MD, PhD (Law)
Partner and Chair, Food, Drug & Device Practice Group, Covington; Brussels, Belgium & Frankfurt, Germany

Aline Lautenberg, LLM
General Counsel, Director Legal & Compliance, MedTech Europe, Brussels, Belgium

Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin; Former Third Secretary, Ministry of Commmerce, People's Republic of China, Beijing, China; Beijing, China

Abdul Luheshi, MBA
Independent Consultant, Ethics and Compliance; Former Compliance Officer, International Markets, Myriad Genetics; Former Executive Director, Global Operations, Ethics & Compliance, EMEA, Astellas; London, UK

Rosa Magistri, CIPP/E
Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire; Zug, Switzerland

Sylvain Mansotte
Co-Founder and Chief Executive Officer, Whispli, Sydney, New South Wales, Australia

Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International; Former Senior Attorney EMEA, Hewlett-Packard; London, UK

Sofie Melis
Director HR and Ethics & Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

Paul J. Melling, JD
Founding Partner, Baker & McKenzie, CIS, Limited, Moscow, Russia

Genevieve Michaux, JD
Partner, King & Spalding, Brussels, Belgium

Vahan Minassian, JD
Digital Compliance Counsel, Compliance Division, Global Programs, Pfizer, Philadelphia, PA, USA

Philippa Montgomerie, CPE, LLB
Vice President EMEA Compliance and Global Programs, Medtronic Limited, Watford, UK

Arthur Muratyan, Esq.
Secretary General, International Society of HealthCare, Ethics and Compliance Professionals (ETHICS), Chair, MedTech Compliance Panel; Former VP-Head of Legal Corporate and Global Compliance Officer, Sanofi

Laura Nassar, PharmD
Vice President, Head of Ethics & Business Integrity, AEME Region, Sanofi; Former Head of Compliance Middle East, Roche Pharmaceuticals; Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon

Gina Nese, JD
Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products; Bellevue, WA, USA

Chrisoula Nikidis, LL.L.
Head of Ethics and Compliance, Takeda Canada; Former Vice President, Ethics, Integrity, & Governance, Innovative Medicines Canada, Toronto, Canada

Lauri G. Opar
Head, Enterprise Risk Management & Risk Analytics, Global Ethics & Compliance, Glaxosmithkline, Brentford, Middlesex, UK

John Patrick Oroho, JD
Executive VP & Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio Bromberg & Newman, PC, Morristown, NJ, USA

Tara Palesh, MS
Senior Director, Compliance Analytics Lead, Pfizer, New York, NY, USA

Giota Papamarkou
Vice-President, Business Ethics Global, France North America & Global Monitoring, Ipsen; Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France

Carrie (Ashcom) Pennington, MBA, PhD
Vice President, Global Compliance Monitoring & Internal Controls, Zimmer Biomet; Former Global Compliance Manager, Books & Records, GE Healthcare, Warsaw, IN, USA

Oscar Perdomo
Director, Pharmaceutical & Life Sciences, Advisory Services, PwC Switzerland, Zurich, Switzerland

Mario Prohasky
Principal, EMEA Compliance Consulting Lead, IQVIA, London, UK

Ariadna Quesada, MSJ
Compliance Director Europe and MEATI, Hillrom; Former Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics; Amsterdam, Netherlands

Amanda N. Raad, JD
Partner and Co-Chair of Global Anti-Corruption and International Risk Practice and R&G Insights Lab, Ropes & Gray, LLP, London, UK

Nadege Rochel, CCEP-I
Global Compliance Manager, Holister Incorporated, Milan, Italy

David Rodin, PhD
Founder and Chief Executive Officer, Principia Advisory, Former Co-Director, Institute for Ethics, Law, and Armed Conflict, Oxford University, Trelex, Vaud, Switzerland

Christian-Claus Roth
Global Head Scientific Engagement Governance, Novartis; Co-president, International Pharmaceutical Congress Advisory Association (IPCAA); Member, Ethics and Business Integrity Committee, IFPMA, Basel, Switzerland

Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy

Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee, F. Hoffmann-La Roche Ltd, Basel, Switzerland

Brian P. Sharkey
Director, US Commercial Compliance & Ethics, Teva Pharmaceuticals, Parsippany, New Jersey, USA

Leonardo Silva, LLM
Vice President, Global Chief Compliance & Privacy Officer, Ferring Pharmaceuticals; Former Head of Compliance, Acino Group, Acino International AG; Former Compliance Director, Emerging Markets, Takeda, Lausanne, Switzerland

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Atlanta, GA, USA

Sapan Singh, MBA
Senior Director Compliance, Stryker Corporation, Mahwah, NJ, USA

Cerstin Steindorf
Global Account Director Healthcare, MCI, Geneva, Switzerland

Robert Stephenson
Director, PwC UK, London, UK

Tiffany Tang
Associate Principal, Global Consulting, IQVIA; Former Senior Manager, Ethics and Compliance, Novo Nordisk; New York, NY

Kathy Tench, MSc
Risk Advisory director & Life Sciences Ethics/Compliance Lead, Deloitte Switzerland, Former Senior Director of Compliance, Optimer Pharmaceuticals, Basil, Switzerland

Heidi Teresi
Director, US Ethics & Compliance, Bausch Health; Former Lead, Education and Communication, US Compliance and Ethics, Bristol-Myers Squibb, Princeton, NJ

Madina Torchinova, JD
Vice President, Head Global Compliance, MorphoSys; Former Regional Head of Compliance, Central & Eastern Europe, Middle East & Africa, and Global OTC, Sandoz; Munich, Germany

Nancy S. Travis, MS
Vice President, International Compliance and Governance, Advanced Medical Technology Association (ADvaMed), Washington, DC, USA

Steve Vincze, JD, LLM, MBA
President and Chief Executive Officer, Trestle Compliance; SVP & US CCO, Cycle Pharmaceuticals; Former VP, Ethics & Compliance Officer, TAP Pharmaceuticals, Boston, MA

Samar Wakim, PharmD
Ethics & Compliance Head MEA, Innovative Medicines, Novartis Pharma Services AG, Dubai, UAE

Caroline H. West, JD
Former Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA, USA

Vanessa Westphal, JD, MS
Head of Compliance Center of Excellence Programs & Support, Merck KGaA, Darmstadt, Frankfurt Am Main Area, Germany

Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, Poland

Elisabethann Wright, LLB
Partner, Hogan Lovells; Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium


Anne-Sophie Bricca, MA, DEA International Law, DES European law
Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT; Chair, Ethics and Compliance Group and seats at the Code Committee, MedTech Europe; Brussels, Belgium

Stephen Nguyen Duc
Vice-President, Global Head of Human Resources and Ethics & Compliance, Medday Pharmaceuticals; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Paris, France

Dominique Laymand, Esq.
Executive Vice President, Chief Ethics & Social Responsibility Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Paris, France

Roeland Van Aelst
Regional Lead Third Party Intermediary Ethics & Compliance EMEA, Johnson & Johnson, President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS),Chairman, MedTech Europe Code Committee, Brussels, Belgium






Tweet using #PharmaCongress

  • Live and curated sessions streamed directly to you through our easy to navigate advanced virtual broadcast platform
  • New content, optimized for online learning, focused on new regulatory developments and managing ethics and compliance programs during the COVID 19 pandemic
  • Engage with faculty through polling, Q & A sessions, chat and direct video messaging
  • Network in real time with other attendees through direct attendee to attendee and group video messaging
  • Access to an extensive video archive of past Congress presentations providing a context for the evolution of the compliance professions and the legal and regulatory setting
  • Virtual exhibit hall featuring innovative solutions, products and services with opportunity to directly contact exhibitors for further information
The International Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.
Click here for more information.



2007 - Brussels

2008 - Paris

2009 - Rome

2010 - Berlin

2011 - Istanbul

2011 - Singapore

2012 - Budapest

2012 - Shanghai

2012 - São Paulo

2013 - Madrid

2013 - Kuala Lumpur

2014 - Dubai

2014 - Mexico City

2014 - Shanghai

2015 - Manila

2016 - Warsaw

2017 - Lisbon

2018 - Vienna

2019 - Athens



Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
June 14-17, 2021
Virtual Online Video Event Live and Archived
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November, 2021


For Congress registration information, visit, email, or call 800-503-8171.

For sponsorship and exhibit information, visit or contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or

For changes or additions, please email your request to:

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.